SCHEMBL26645019

SCHEMBL26645019

CC(C)(C)OC(=O)N1CCn2nc(-c3ccc(Cl)cc3)c(-c3ccncc3)c2C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1D P48730 4/20 0.47
CSNK1E P49674 4/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
GPR119 Q8TDV5 1/20 0.42
MAPK11 Q15759 3/20 0.41
MAPK14 Q16539 3/20 0.41
STS P08842 1/20 0.41
ADK P55263 1/20 0.40
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
POLB P06746 1/20 0.39
CKS1B P61024 2/20 0.39
SKP1 P63208 2/20 0.39
SKP2 Q13309 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP3A5 P20815 2/20 0.39
CACNB4 O00305 2/20 0.39
CACNA1A O00555 2/20 0.39
CACNA1G O43497 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30623035 0.94 CSNK1D (0.43) CSNK1DCSNK1EMEN1KMT2AGPR119
SCHEMBL26645250 0.91 CSNK1D (0.48) CSNK1DCSNK1EGPR119CKS1BSKP1
SCHEMBL26645466 0.91 CSNK1D (0.49) CSNK1DCSNK1EGPR119POLBCKS1B
SCHEMBL30622922 0.90 CSNK1E (0.43) CSNK1DCSNK1EMEN1KMT2AMAPK11
SCHEMBL26645443 0.90 CSNK1E (0.43) CSNK1DCSNK1EMEN1KMT2AMAPK11
SCHEMBL26645681 0.90 CSNK1E (0.48) CSNK1DCSNK1EGPR119MAPK11MAPK14
SCHEMBL26645014 0.89 CSNK1E (0.43) CSNK1DCSNK1EMEN1KMT2AGPR119
SCHEMBL30622825 0.89 CSNK1E (0.43) CSNK1DCSNK1EMEN1KMT2AGPR119
SCHEMBL26645399 0.89 CSNK1E (0.46) CSNK1DCSNK1EMEN1KMT2AGPR119
SCHEMBL26645705 0.89 CSNK1D (0.46) CSNK1DCSNK1EGPR119MAPK11MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4519265-A1 IRREVERSIBLE MUTEGFR INHIBITORS Bayer Aktiengesellschaft (DE) 2025-03-12 EP disclosed
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 WO disclosed